CAH - Cardinal Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $278.22 DETAILS

Stock News

The Dividend Aristocrats Ranked By Quality Scores (October 2026)

I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.

Oct 23, 2026 08:25 AM • seekingalpha.com

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.

Oct 20, 2026 03:01 PM • zacks.com

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) closed at $253.71 in the latest trading session, marking a +2.41% move from the prior day.

Oct 15, 2026 03:15 PM • zacks.com

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge

As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.

Oct 15, 2026 12:37 PM • zacks.com

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Oct 13, 2026 06:45 AM • zacks.com

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Oct 13, 2026 06:41 AM • zacks.com

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.

Oct 13, 2026 06:41 AM • zacks.com

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.

Oct 06, 2026 07:46 AM • zacks.com

Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know

Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.

Oct 05, 2026 03:01 PM • zacks.com

Cardinal Health, Inc. $CAH Position Decreased by Park National Corp OH

Park National Corp OH trimmed its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 8.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 52,115 shares of the company's stock after selling 4,578 shares during the

Oct 05, 2026 09:37 AM • defenseworld.net

MassMutual Private Wealth & Trust FSB Buys 106,709 Shares of Cardinal Health, Inc. $CAH

MassMutual Private Wealth and Trust FSB increased its stake in Cardinal Health, Inc. (NYSE: CAH) by 6,447.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 108,364 shares of the company's stock after purchasing an additional 106,709 shares during

Oct 05, 2026 03:05 AM • defenseworld.net

5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.

Oct 01, 2026 06:01 AM • zacks.com

Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services. "We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.

Oct 01, 2026 02:50 AM • prnewswire.com

Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Oct 01, 2026 02:45 AM • prnewswire.com

Cardinal Health: I'm Still Buying After Checking The Numbers

Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. CAH delivered 14% revenue growth, 20% gross margin expansion, and doubled free cash flow, despite ongoing thin margins and higher current liabilities. FY2027 guidance targets 13-15% non-GAAP EPS growth, with profit improvement expected from both Pharmaceutical and Specialty Solutions and higher-margin 'Other' segments.

Sep 30, 2026 11:01 AM • seekingalpha.com

At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?

At-Home Solutions is powering CAH???s growth strategy as investments, acquisitions and technology help it scale in home-based healthcare.

Sep 28, 2026 11:35 AM • zacks.com

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade

Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.

Sep 25, 2026 03:01 PM • zacks.com

Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?

CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.

Sep 24, 2026 09:46 AM • zacks.com

Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Sep 23, 2026 06:45 AM • zacks.com